Navigation Links
Scripps scientist awarded $1.8 million to develop new approaches to lung cancer therapy
Date:1/30/2014

JUPITER, FL, January 30, 2014 Scientists from the Florida campus of The Scripps Research Institute (TSRI) have been awarded approximately $1.8 million from the National Cancer Institute of the National Institutes of Health to identify the signaling pathways that underlie lung cancer and to use this information to develop new therapeutic approaches.

Joseph Kissil, a TSRI associate professor, will be principal investigator of the new five-year grant, which extends a study that began in 2006.

Although death rates from lung cancer have fallen in the last 20 years, survival rates are still not good, largely because of a lack of effective treatments for advanced disease.

Kissil's research into non-small cell lung cancer, the most common form of the disease, has shown that a well-known cancer-causing gene implicated in a number of malignancies plays a far more critical role than previously thought. Activating mutations of the K-ras gene are found in more than a third of lung cancers.

"There are clear links between K-ras-induced lung cancer and the receptor known as Notch 1," Kissil said. "A loss of this receptor results in reduced tumor growth. The new grant will let us continue our research into Notch signaling pathways as potentially important therapeutic options for treatment of this disease."


'/>"/>

Contact: Eric Sauter
esauter@scripps.edu
267-337-3859
Scripps Research Institute
Source:Eurekalert  

Page: 1

Related biology news :

1. Scripps Florida scientists offer new insight into neuron changes brought about by aging
2. Scripps leads first global snapshot of key coral reef fishes
3. Scripps Research Institute scientists achieve most detailed picture ever of key part of hepatitis C
4. Scripps oceanography researchers engineer breakthrough for biofuel production
5. NIH awards Scripps Translational Science Institute $29 million grant
6. James Cameron to be publicly honored with Scripps Nierenberg Prize
7. Scripps Research announces research & license agreement with Janssen Pharmaceuticals
8. John Moores gives $2 million to Scripps Research to develop river blindness field test
9. Scripps Research and Takeda Pharmaceuticals announce expanded research collaboration
10. Vibrant mix of marine life found at extreme ocean depths, Scripps analysis reveals
11. Scripps Florida scientist awarded prestigious Javits Neuroscience Investigator Award
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Scripps scientist awarded $1.8 million to develop new approaches to lung cancer therapy
(Date:2/3/2017)... WASHINGTON , Feb. 3, 2017 A ... Identity Strategy Partners, LLP (IdSP) . Designed to ... in the complex identity market, founding partners Mark ... nearly 35 combined years just in identity expertise that ... tank and non-profit leadership. The Crego-Kephart combined expertise has ...
(Date:2/2/2017)... -- Central to its deep commitment to honor the ... Prize Foundation today announced the laureates of the ... in their respective fields of Life Sciences and ... recognized with the 2017 Japan Prize for original ... the advancement of science and technology, but also ...
(Date:1/30/2017)... 2017   Invitae Corporation (NYSE: ... companies, today announced that it will report its fourth ... guidance on Monday, February 13, 2017, and Invitae,s management ... 4:45 p.m. Eastern / 1:45 p.m. Pacific. ... review financial results, guidance, and recent developments and will ...
Breaking Biology News(10 mins):
(Date:2/17/2017)... According to a new ... Service), Type (Safety, Efficacy, Validation), Disease Indication (Cancer, ... Development, Disease-Risk) - Global Forecast to 2021" published ... USD 53.34 Billion by 2021 from USD 27.95 ... 13.8% during the forecast period (2016-2021). ...
(Date:2/17/2017)... Feb. 17, 2017  Protagonist Therapeutics, Inc. (NASDAQ: ... its oral peptide drug candidates, PTG-100 and PTG-200, ... European Crohn,s and Colitis Organization (ECCO).  The ECCO ... Spain from February 15 – 18, ... data on Protagonist drug candidates PTG-100 and PTG-200. ...
(Date:2/16/2017)... Calif. and GREENWICH, Conn. ... a private investment firm focused on venture growth ... the promotion of Josh Richardson , M.D. ... on investments in biotechnology companies.  He is a ... played important roles in Longitude,s investments in Aimmune ...
(Date:2/16/2017)... , Feb. 16, 2017   Capricor Therapeutics, ... clinical-stage biotechnology company developing first-in-class biological therapies for ... it has elected to terminate its license agreement ... receptor agonists, including Cenderitide. "Our decision ... as we prioritize our efforts to advance our ...
Breaking Biology Technology: